Download Citation
Article Source:
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study
Siddall H,
Quint D,
Pandya H,
Powley W,
Shabbir S,
et al.
(2020)
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
PLOS ONE 15(11): e0240964.
https://doi.org/10.1371/journal.pone.0240964